Altered Brain Function and Causal Connectivity Induced by Repetitive Transcranial Magnetic Stimulation Treatment for Major Depressive Disorder

被引:9
|
作者
Guan, Muzhen [1 ,2 ]
Wang, Zhongheng [2 ]
Shi, Yanru [2 ]
Xie, Yuanjun [3 ]
Ma, Zhujing [4 ]
Liu, Zirong [5 ]
Liu, Junchang [2 ]
Gao, Xinyu [4 ]
Tan, Qingrong [2 ]
Wang, Huaning [2 ]
机构
[1] Xian Med Univ, Dept Mental Hlth, Xian, Peoples R China
[2] Air Force Med Univ, Xijing Hosp, Deptartment Psychiat, Xian, Peoples R China
[3] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian, Peoples R China
[4] Air Force Med Univ, Deptartment Psychol, Xian, Peoples R China
[5] Yulin Fifth Hosp, Deptartment Psychiat, Yuling, Peoples R China
关键词
major depressive disorder; amplitude of the low-frequency fluctuation; regional homogeneity; Granger causality analysis (GCA); repetitive transcranial magnetic stimulation; LOW-FREQUENCY FLUCTUATIONS; DEFAULT-MODE NETWORK; DRUG-NAIVE PATIENTS; RESTING-STATE; MDD PATIENTS; 1ST EPISODE; 1ST-EPISODE; AMPLITUDE; METAANALYSIS; MATTER;
D O I
10.3389/fnins.2022.855483
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
ObjectiveRepetitive transcranial magnetic stimulation (rTMS) can effectively improve depression symptoms in patients with major depressive disorder (MDD); however, its mechanism of action remains obscure. This study explored the neuralimaging mechanisms of rTMS in improving depression symptoms in patients with MDD. MethodsIn this study, MDD patients with first-episode, drug-naive (n = 29) and healthy controls (n = 33) were enrolled. Depression symptoms before and after rTMS treatment were assessed using the Hamilton Depression Rating Scale (HAMD-17). Resting-state functional magnetic resonance imaging (rs-fMRI) data were collected both before and after the treatment. Changes in the brain function after the treatment were compared using the following two indices: the amplitude of the low-frequency fluctuation (ALFF) and regional homogeneity (ReHo), which are sensitive for evaluating spontaneous neuronal activity. The brain region with synchronous changes was selected as the seed point, and the differences in the causal connectivity between the seed point and whole brain before and after rTMS treatment were investigated via Granger causality analysis (GCA). ResultsBefore treatment, patients with MDD had significantly lower ALFF in the left superior frontal gyrus (p < 0.01), higher ALFF in the left middle frontal gyrus and left precuneus (p < 0.01), and lower ReHo in the left middle frontal and left middle occipital gyri (p < 0.01) than the values observed in healthy controls. After the rTMS treatment, the ALFF was significantly increased in the left superior frontal gyrus (p < 0.01) and decreased in the left middle frontal gyrus and left precuneus (p < 0.01). Furthermore, ReHo was significantly increased in the left middle frontal and left middle occipital gyri (p < 0.01) in patients with MDD. Before treatment, GCA using the left middle frontal gyrus (the brain region with synchronous changes) as the seed point revealed a weak bidirectional causal connectivity between the middle and superior frontal gyri as well as a weak causal connectivity from the inferior temporal to the middle frontal gyri. After treatment, these causal connectivities were strengthened. Moreover, the causal connectivity from the inferior temporal gyrus to the middle frontal gyri negatively correlated with the total HAMD-17 score (r = -0.443, p = 0.021). ConclusionrTMS treatment not only improves the local neural activity in the middle frontal gyrus, superior frontal gyrus, and precuneus but also strengthens the bidirectional causal connectivity between the middle and superior frontal gyri and the causal connectivity from the inferior temporal to the middle frontal gyri. Changes in these neuroimaging indices may represent the neural mechanisms underlying rTMS treatment in MDD.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] An Update on Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder
    Trevizol, Alisson P.
    Blumberger, Daniel M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (04) : 747 - 762
  • [2] Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder
    Corlier, Juliana
    Wilson, Andrew
    Hunter, Aimee M.
    Vince-Cruz, Nikita
    Krantz, David
    Levitt, Jennifer
    Minzenberg, Michael J.
    Ginder, Nathaniel
    Cook, Ian A.
    Leuchter, Andrew F.
    [J]. CEREBRAL CORTEX, 2019, 29 (12) : 4958 - 4967
  • [3] Repetitive Transcranial Magnetic Stimulation Improves Amygdale Functional Connectivity in Major Depressive Disorder
    Chen, Fu-jian
    Gu, Chuan-zheng
    Zhai, Ning
    Duan, Hui-feng
    Zhai, Ai-ling
    Zhang, Xiao
    [J]. FRONTIERS IN PSYCHIATRY, 2020, 11
  • [4] Repetitive transcranial magnetic stimulation and pharmacological treatment in patients with major depressive disorder
    Magnano, F.
    Concerto, C.
    Cannavo, D.
    Lanza, G.
    Pennisi, M.
    Aguglia, E.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S267 - S267
  • [5] Repetitive transcranial magnetic stimulation for major depressive disorder: A review
    Daskalakis, Z. Jeff
    Levinson, Andrea J.
    Fitzgerald, Paul B.
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2008, 53 (09): : 555 - 566
  • [6] Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder
    Jha, Shailesh
    Chadda, Rakesh K.
    Kumar, Nand
    Bal, C. S.
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2016, 21 : 1 - 6
  • [7] Transcranial Magnetic Stimulation Induced Brain Response in Major Depressive Disorder
    Mills-Finnerty, Colleen
    Wright, Rachael
    Cole, Carena
    Etkin, Amit
    [J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S215 - S215
  • [8] Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder
    White, Daniela
    Tavakoli, Sason
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2015, 27 (03) : 192 - 196
  • [9] Predictors of response to repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder
    Beuzon, G.
    Timour, Q.
    Saoud, M.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (01): : 3 - 9
  • [10] REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN COMBINATION WITH PAROXETINE FOR MAJOR DEPRESSIVE DISORDER
    Sun, L. X.
    Zhang, H. S.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 27 - 27